Bio-Rad Laboratories, Inc. (BIO)

Bio-Rad Laboratories Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	8,484	9,411	12,541	22,605	17,389	11,077
Market Cap Growth	-30.42%	-24.96%	-44.52%	29.99%	56.99%	59.20%
Enterprise Value	8,233	9,203	12,133	21,953	16,618	10,608
PE Ratio	-	-14.77	-3.46	5.31	4.56	6.30
PS Ratio	3.26	3.52	4.47	7.74	6.83	4.79
PB Ratio	0.94	1.08	1.30	1.65	1.76	1.93
P/FCF Ratio	45.68	43.07	153.26	42.19	36.50	30.81
P/OCF Ratio	24.48	25.10	64.49	33.77	29.73	24.19
EV/Sales Ratio	3.16	3.45	4.33	7.51	6.53	4.59
EV/EBITDA Ratio	-24.37	-11.49	-2.60	4.03	3.36	4.64
EV/EBIT Ratio	-24.37	-11.49	-2.60	4.03	3.36	4.64
EV/FCF Ratio	44.33	42.13	148.27	40.98	34.88	29.51
Debt / Equity Ratio	0.15	0.16	0.14	0.02	0.02	0.11
Debt / EBITDA Ratio	-3.55	-1.76	-0.30	0.04	0.05	0.29
Debt / FCF Ratio	7.54	6.43	16.96	0.42	0.47	1.81
Quick Ratio	4.50	4.02	4.03	1.91	2.24	1.67
Current Ratio	6.57	5.83	5.55	2.92	3.39	2.41
Asset Turnover	0.21	0.21	0.21	0.18	0.23	0.31
Interest Coverage	-7.99	-16.20	-122.43	3514.25	225.97	97.56
Return on Equity (ROE)	-3.70%	-7.20%	-39.00%	33.20%	47.20%	33.10%
Return on Assets (ROA)	-2.60%	-5.10%	-27.60%	25.50%	34.90%	23.70%
Return on Capital (ROIC)	3.07%	3.33%	4.39%	2.81%	3.23%	2.79%
Earnings Yield	-3.80%	-6.77%	-28.93%	18.82%	21.93%	15.88%
FCF Yield	2.19%	2.32%	0.65%	2.37%	2.74%	3.25%
Buyback Yield / Dilution	4.07%	1.93%	1.40%	-0.16%	0.08%	0.15%
Total Shareholder Return	4.07%	1.93%	1.40%	-0.16%	0.08%	0.15%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).